Russian drugmakers aim to increase pharma exports this year

Leading Russian pharmaceutical producers plan to significantly increase exports of their drugs to foreign markets during the next several years and to localize their production, according to recent statements by the companies, reports The Pharma Letter’s local correspondent.

As part of these plans, particular attention will be paid to increasing supplies to Southeast Asia and Latin America regions.

For example, Biocad, Russia’s leading biotech company, already supplies its products to 21 countries worldwide and plans to further expand the geography of its supplies this year. In addition to exports, the company plans greater localization of its production outside Russia.